Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.

@article{Cinciripini2013EffectsOV,
  title={Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.},
  author={Paul M. Cinciripini and Jason D. Robinson and Maher A Karam-Hage and Jennifer A. Minnix and Cho Y. Lam and Francesco Versace and Victoria L. Brown and Jeffrey M. Engelmann and David W. Wetter},
  journal={JAMA psychiatry},
  year={2013},
  volume={70 5},
  pages={522-33}
}
IMPORTANCE Given the actions of varenicline tartrate and bupropion hydrochloride sustained-release (SR) on neurobiological targets related to affect and reward, it is thought that the modulation of nicotine withdrawal symptoms may contribute to their effectiveness. OBJECTIVE To assess the relative efficacy of varenicline and bupropion SR plus intensive counseling on smoking cessation and emotional functioning. DESIGN AND SETTING Placebo-controlled randomized clinical trial at a university… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up

Annals of behavioral medicine : a publication of the Society of Behavioral Medicine • 2017
View 2 Excerpts

Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco • 2017

References

Publications referenced by this paper.
Showing 1-10 of 35 references

Development and validation of brief measures of positive and negative affect: the PANAS scales

D Watson, LA Clark, A. Tellegen
J Pers Soc Psychol • 1988
View 2 Excerpts
Highly Influenced

Signs and symptoms of tobacco withdrawal.

Archives of general psychiatry • 1986
View 3 Excerpts
Highly Influenced

A comparison of psychological and pharmacological treatment in smoking cessation

Journal of Behavioral Medicine • 1982
View 2 Excerpts
Highly Influenced

and Drug Administration

US Foo
Information for healthcare professionals: varenicline (marketed as Chantix) and bupropion (marketed as Zyban, Wellbutrin, and generics). FDA alert. July 1, 2009. http://www.fda.gov/Drugs /DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders /DrugSafetyInformationforHeathcareProfessional • 2013
View 1 Excerpt

A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco • 2012

Nicotine receptor partial agonists for smoking cessation

K Cahill, LF Stead, T. Lancaster
[update in Cochrane Database Syst Rev. 2012;(4):CD006103]. Cochrane Database Syst Rev • 2011

Quitting smoking among adults--United States, 2001-2010.

American Smokeout, Thomas R Frieden, +37 authors Rachel B. Kaufmann
MMWR. Morbidity and mortality weekly report • 2011

Similar Papers

Loading similar papers…